Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial was listed as 'withdrawn' — can you tell me why it was pulled before it started, and whether that tells us anything important about the safety or feasibility of targeting airway basal cells in BOS?
2. 2Since this study was focused on lab and animal research — things like mouse models and ferret transplants — rather than treating patients directly, are there any other clinical trials for BOS that have moved beyond that stage and might be worth discussing for my situation?
3. 3The trial was looking at how airway basal cells proliferate and differentiate in BOS — is that mechanism something my care team already considers when managing my condition, and are there any approved treatments that work along those lines?
4. 4Given that this study never enrolled patients, what does current evidence actually say about whether airway basal cell dysfunction is a meaningful driver of my BOS, and should that shape how we think about my treatment plan?
5. 5Are there other active research programs or centers specializing in BOS — particularly ones studying basal cell biology or targeted therapies — that you'd recommend I look into given that this trial is no longer moving forward?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.